glp 1 drugs for obesity Chart: in 8 Americans Now Use GLP-1 Weight Loss Market Overview: GLP-1 Agonists and
Description
Who benefits most from this therapy
Data extraction The baseline characteristics and outcomes data were extracted using a Microsoft Excel extraction sheet by two authors, and a senior author settled disagreements
For those who have been on medication long-term and notice a slowdown, a semaglutide plateau or tirzepatide losing effectiveness can occur
BMJ Open 7 , e015735 (2017)
